An open-label, randomized, single dose, three-way crossover, six sequence pilot study to evaluate the relative bioavailability of one amlodipine 10 mg tablet and rosuvastatin 20 mg tablet to two fixed dose combination tablet formulations of amlodipine (10 mg) and rosuvastatin (20 mg) in healthy adult male and female subjects under fasting conditions
Phase of Trial: Phase I
Latest Information Update: 16 May 2017
Price : $35 *
At a glance
- Drugs Amlodipine/rosuvastatin (Primary) ; Amlodipine; Rosuvastatin
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 01 Mar 2016 Results published in the Clinical Pharmacology in Drug Development.
- 25 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Jun 2014 Planned End Date changed from 1 Jun 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov record.